Accenture plc (ACN)

Verve Therapeutics Revenue

Accenture had revenue of $17.73B in the quarter ending May 31, 2025, with 7.66% growth. This brings the company's revenue in the last twelve months to $68.48B, up 6.21% year-over-year. In the fiscal year ending August 31, 2024, Accenture had annual revenue of $64.90B with 1.22% growth.

• Revenue (ttm): $68.48B
• Revenue Growth: +6.21%
• P/S Ratio: 2.21
• Revenue / Employee: $88,479
• Employees: 774,000
• Market Cap: 149.82B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Aug 31, 2024	64.90B	784.72M	1.22%
Aug 31, 2023	64.11B	2.52B	4.09%
Aug 31, 2022	61.59B	11.06B	21.89%
Aug 31, 2021	50.53B	6.21B	14.00%
Aug 31, 2020	44.33B	1.11B	2.57%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.